Belite Bio price target raised to $266 from $200 at Cantor Fitzgerald

Cantor Fitzgerald raised the firm’s price target on Belite Bio (BLTE) to $266 from $200 and keeps an Overweight rating on the shares. Recent commentary suggested a possibility of a much higher WAC than the $200K/year the firm was modeling, the analyst tells investors in a research note. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on BLTE: Disclaimer & DisclosureReport an Issue ...